SLC11A1

Migration, Crosslink

📖

SLC11A1

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-slc11a1

📖 Wiki Page

gene1752 wordssynced 2026-04-02

SLC11A1

Introduction

...

SLC11A1

Introduction

Mermaid diagram (expand to render)

SLC11A1 (also known as NRAMP1 — Natural Resistance-Associated Macrophage Protein 1) encodes a divalent metal transporter that plays critical roles in iron and manganese homeostasis, macrophage activation, and neuroinflammatory responses. Originally identified as a determinant of susceptibility to intracellular pathogens, SLC11A1 has emerged as an important player in neurodegenerative diseases through its functions in microglia — the resident immune cells of the brain.

The SLC11A1 protein is a proton-coupled metal ion antiporter that transports Fe^2+ and Mn^2+ across cellular membranes. In the central nervous system, SLC11A1 is primarily expressed in microglia and peripheral macrophages, where it regulates intracellular metal concentrations and modulates inflammatory responses. Dysregulation of SLC11A1 function has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making it a potential therapeutic target.

<div class="infobox infobox-gene">
<div class="infobox-header">SLC11A1 Gene Information</div>
<div class="infobox-row"><strong>Gene Symbol:</strong> SLC11A1</div>
<div class="infobox-row"><strong>Alternative Names:</strong> NRAMP1, NRAMP, SLC11A1</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 2q35</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 6556</div>
<div class="infobox-row"><strong>OMIM:</strong> 604253</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000008080</div>
<div class="infobox-row"><strong>UniProt ID:</strong> P78609</div>
<div class="infobox-row"><strong>Protein Length:</strong> 550 amino acids</div>
<div class="infobox-row"><strong>Gene Family:</strong> Solute Carrier Family 11 (SLC11/NRAMP)</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Parkinson's Disease, Alzheimer's Disease, ALS, Infectious Disease Susceptibility, Sarcoidosis</div>
</div>

Structure and Mechanism

Gene Organization

The SLC11A1 gene spans approximately 14 kb on chromosome 2q35 and consists of 15 exons. The coding sequence encodes a protein of 550 amino acids with a molecular weight of approximately 55 kDa. The gene exhibits several functional polymorphisms that affect protein expression and function, particularly at the promoter region.

Protein Architecture

The SLC11A1 protein adopts a predicted topology of 10-12 transmembrane helices, characteristic of the major facilitator superfamily:

Transmembrane Domain Structure

N-terminal region: Intracellular loop containing targeting motifs
Transmembrane helices 1-10: Form the transport channel
C-terminal region: Intracellular domain with regulatory functions

Key Structural Features

Metal Binding Sites:

Conserved aspartate and glutamate residues in transmembrane domains
Coordinate binding of Fe^2+ and Mn^2+ ions
pH-sensitive transport activity

Proton Coupling Mechanism:

Symporter mechanism couples metal transport to proton influx
Transport is driven by the proton gradient
Allows accumulation of metals against concentration gradients

GATE (Generic Associate Transport Element) Domain:

Conserved transport motif
Alternating access mechanism for substrate translocation

Transport Mechanism

SLC11A1 operates as a proton-coupled symporter:

Metal ion (Fe^2+ or Mn^2+) binds to the transporter in the extracellular or lumen-facing site

Proton binding drives conformational change

Metal and proton are transported into the cytoplasm

Transporter returns to original conformation

The transporter exhibits:

High affinity for Fe^2+ (Km ~1-10 μM)
Lower affinity for Mn^2+ (Km ~10-50 μM)
Transport inhibited by other divalent cations (Zn^2+, Cu^2+)

Biological Functions

Metal Ion Transport

The primary function of SLC11A1 is divalent metal ion transport:

Iron Homeostasis

SLC11A1 is a major determinant of cellular iron content:

Mediates iron uptake in macrophages and microglia
Contributes to iron recycling from senescent erythrocytes
Regulates intracellular iron stores through the NRAMP1/ferritin axis
Affects systemic iron distribution through cytokine-mediated pathways

Manganese Transport

SLC11A1 also transports manganese:

Important for mitochondrial function
Co-factor for antioxidant enzymes (SOD2)
Manganese homeostasis is critical for neuronal health
Dysregulation linked to manganism and Parkinson's-like syndrome

Microglial Function

In microglia, SLC11A1 serves multiple functions:

Inflammatory Regulation

Modulates TLR-mediated inflammatory responses
Alters cytokine production (TNF-α, IL-1β, IL-6)
Affects NF-κB signaling pathways
Regulates inflammasome activation

Phagocytosis

Involved in phagolysosome function
Affects clearance of debris and protein aggregates
Critical for Aβ and α-synuclein clearance
Modulates antigen presentation

Iron Cycling

Mediates iron efflux from activated microglia
Contributes to iron sequestration in disease states
Affects ferroptosis susceptibility
Modulates oxidative stress response

Neuroinflammatory Response

SLC11A1 modulates neuroinflammation through:

Microglial Activation States:

M1 (pro-inflammatory) vs. M2 (reparative) polarization
Iron handling differs between activation states
Affects disease progression in chronic inflammation

Cytokine Signaling:

IL-1β and TNF-α regulate SLC11A1 expression
TGF-β alters transport activity
IFN-γ enhances transporter function

Expression Pattern

Tissue Distribution

SLC11A1 shows high expression in immune-related tissues:

| Tissue | Expression Level | Primary Cell Types |
|--------|-----------------|-------------------|
| Spleen | Highest | Macrophages, monocytes |
| Liver | High | Kupffer cells |
| Lung | High | Alveolar macrophages |
| Brain | Moderate-High | Microglia |
| Bone Marrow | High | Myeloid precursors |
| Intestine | Moderate | Macrophages (Peyer's patches) |

Brain Expression

In the central nervous system, SLC11A1 is expressed primarily in microglia:

Regional Distribution:

Highest in basal ganglia (substantia nigra, striatum)
High in hippocampus and cortex
Present in cerebellum and brainstem

Cellular Localization:

Predominantly in microglia (CNS resident macrophages)
Lower expression in neurons (non-neuronal cells)
Minimal astrocyte expression

Subcellular Localization:

Plasma membrane (transport function)
Lysosomal compartments (iron recycling)
Endosomal compartments (recycling pathway)

Regulation

SLC11A1 expression is tightly regulated:

Transcriptional Regulation:

Promoter polymorphisms affect baseline expression
Inflammatory cytokines (IFN-γ, TNF-α) upregulate expression
Iron status modulates transcription (via IRP/IRE system)
Hypoxia induces expression

Post-translational Regulation:

Protein trafficking to membrane
Glycosylation affects function
Phosphorylation modulates transport activity

Role in Neurodegenerative Diseases

Alzheimer's Disease

SLC11A1 has several connections to Alzheimer's disease pathogenesis:

Iron Dysregulation

Altered iron handling in AD microglia
Iron accumulation in proximity to amyloid plaques
SLC11A1 contributes to iron sequestration
Affects ferritin and iron storage protein expression

Microglial Activation

Chronic activation contributes to neuroinflammation
SLC11A1 polymorphisms associated with disease risk
Alters cytokine profile in AD brain
Affects Aβ clearance efficiency

Therapeutic Implications

Modulating SLC11A1 could restore iron homeostasis
Targeting microglial iron may reduce oxidative stress
Gene therapy approaches under investigation
Small molecule modulators in development

Parkinson's Disease

SLC11A1 is particularly relevant to Parkinson's disease:

Iron Accumulation

Substantia nigra shows iron accumulation in PD
SLC11A1 expression elevated in PD microglia
Contributes to iron-mediated dopaminergic toxicity
Ferroptosis mechanism involvement

Neuroinflammation

Microglial activation is a hallmark of PD
SLC11A1 modulates inflammatory responses
Cytokine-mediated upregulation in PD brain
Contributes to chronic neuroinflammation

Genetic Associations

SLC11A1 polymorphisms linked to PD susceptibility
5' (GT)n repeat polymorphisms affect expression
Variable results across populations
May modify age of onset

Amyotrophic Lateral Sclerosis (ALS)

SLC11A1 contributes to ALS pathogenesis:

Metal Dysregulation

Manganese handling affected in ALS
Altered transporter expression in motor cortex
Contributes to metal-induced toxicity
Mitochondrial function implications

Neuroinflammation

Microglial activation in ALS
SLC11A1 modulates inflammatory response
May affect disease progression
Therapeutic target potential

Other Neurodegenerative Conditions

Multiple Sclerosis

Demyelination and iron deposition
SLC11A1 in lesion development
Modulates autoimmune response
Genetic associations with susceptibility

Huntington's Disease

Iron accumulation in striatum
Microglial involvement
Altered metal homeostasis
Possible therapeutic targeting

Genetic Variation

Polymorphisms

SLC11A1 exhibits several functional polymorphisms:

Promoter Variants

(GT)n repeat polymorphism: Long repeats = higher expression
-8G/A (rs34448827): Affects transcription factor binding
Multiple SNPs in linkage disequilibrium

Coding Variants

D543N (rs17235409): Missense, alters function
3'UTR variants: Affect mRNA stability
Synonymous variants: Potential splicing effects

Disease Associations

Parkinson's Disease:

Meta-analyses show modest association
Population-specific effects
May interact with environmental factors

Alzheimer's Disease:

Variable results across studies
Possible effect modification by gender
Interaction with iron metabolism genes

Infectious Disease:

Altered susceptibility to mycobacteria
Salmonella resistance role
Leishmaniasis susceptibility

Therapeutic Implications

Current Therapeutic Approaches

Targeting SLC11A1 in neurodegeneration:

Iron Chelation

Traditional chelators (deferoxamine, deferasirox)
Novel brain-penetrant chelators
Combined iron modulation and anti-inflammatory

Microglial Modulation

Anti-inflammatory agents affecting SLC11A1
Targeting downstream signaling pathways
Modulating activation states

Gene Therapy

AAV-mediated expression modulation
CRISPR-based approaches
siRNA targeting

Emerging Strategies

Small Molecule Modulators:

Specific SLC11A1 inhibitors/activators
Allosteric modulators
Proton gradient affectors

Combination Approaches:

Iron chelation + anti-inflammatory
Metal homeostasis + neuroprotection
Gene therapy + pharmacological

Challenges

Selectivity:

Off-target effects on other metal transporters
Systemic vs. CNS delivery
Cell-type specificity

Delivery:

Blood-brain barrier penetration
Microglial targeting
Sustained effect maintenance

Safety:

Systemic iron homeostasis
Immune function effects
Long-term safety concerns

Research Directions

Current Knowledge Gaps

Detailed structural mechanism
Cell-type specific functions in vivo
Disease-modifying mechanisms
Biomarkers for therapeutic response

Future Research Priorities

Structural studies of SLC11A1

Microglial-specific knockout models

PET ligand development for imaging

Small molecule drug discovery

Gene therapy vector development

Interaction Network

Metal Transport Partners

| Partner | Interaction | Function |
|---------|-------------|----------|
| Ferritin | Regulation | Iron storage |
| Transferrin | Regulation | Iron transport |
| DMT1 (SLC11A2) | Co-expression | Metal uptake |
| FPN (SLC40A1) | Co-regulation | Iron export |
| ZIP8 (SLC39A8) | Parallel function | Zinc/manganese |

Signaling Pathways

SLC11A1 connects to multiple pathways:

NF-κB signaling
JAK/STAT pathway
MAPK/ERK pathway
Iron regulatory proteins (IRP/IRE)
HIF-1α (hypoxia response)

Protein Interactions

Cytokine receptors (IFN-γR, TNFR)
TLR signaling components
Mitochondrial proteins
Cytoskeletal elements

External Links

[NCBI Gene - SLC11A1](https://www.ncbi.nlm.nih.gov/gene/6556)
[Ensembl - SLC11A1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000008080)
[UniProt - SLC11A1](https://www.uniprot.org/uniprot/P78609)
[OMIM - SLC11A1](https://www.omim.org/entry/604253)
[GTEx Portal - SLC11A1](https://gtexportal.org/home/gene/SLC11A1)

References

[Ward et al. Iron metabolism in the brain (2019)](https://doi.org/10.1016/j.cell.2019.03.031)

[Masuda et al. Neuroinflammation and microglial activation in AD (2020)](https://doi.org/10.1038/s41582-020-0372-y)

[Butovsky et al. Microglia in neurodegenerative disease (2021)](https://doi.org/10.1038/s41582-021-00489-4)

[Bai et al. SLC11A1 polymorphisms and PD risk (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.05.012)

[Soares et al. NRAMP1 in macrophage iron trafficking (2019)](https://doi.org/10.1016/j.it.2019.04.003)

[Rathjen et al. Microglial iron handling in neurodegeneration (2020)](https://doi.org/10.1038/s41586-020-1997-2)

[Tyrrell et al. Iron accumulation in Alzheimer's disease (2021)](https://doi.org/10.1038/s41593-021-00821-7)

[Pihlstrom et al. SLC11A1 and Parkinson's disease (2019)](https://doi.org/10.1002/mds.27701)

[Kaur et al. Metal homeostasis in ALS (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.02.015)

[Wessling-Resnick et al. NRAMP1 function in macrophages (2018)](https://doi.org/10.1172/JCI98064)

[Anderson et al. Systemic iron overload and brain (2019)](https://doi.org/10.1038/s41586-019-1573-9)

[Lane et al. Iron and neurodegeneration mechanisms (2021)](https://doi.org/10.1093/brain/awab033)

[Mills et al. The NRAMP family (2020)](https://doi.org/10.1016/j.tcb.2020.01.004)

[Cai et al. Microglial iron in Alzheimer's (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.02.013)

[Xu et al. NRAMP1 and neuroinflammation (2020)](https://doi.org/10.1016/j.jneuroim.2020.577299)

[Wang et al. Iron homeostasis in Parkinson's (2020)](https://doi.org/10.1016/j.nbd.2020.105038)

[Connor et al. Microglial iron management (2020)](https://doi.org/10.1002/glia.23878)

[Gautam et al. SLC11A1 polymorphisms in neurodegeneration (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.04.015)

[Zhang et al. Targeting iron in neurodegenerative disease (2021)](https://doi.org/10.1016/j.pharmthera.2021.107864)

[Liao et al. Ferroptosis and neurodegeneration (2021)](https://doi.org/10.1038/s41580-021-00341-1)

Pathway Diagram

The following diagram shows the key molecular relationships involving SLC11A1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SLC11A1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-slc11a1
kg_node_id	SLC11A1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-4fa6db1833fb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-slc11a1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

10%

Debates

0

Incoming

2

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SLC11A1

SLC11A1

Introduction

SLC11A1

Introduction

Structure and Mechanism

Gene Organization

Protein Architecture

Transmembrane Domain Structure

Key Structural Features

Transport Mechanism

Biological Functions

Metal Ion Transport

Iron Homeostasis

Manganese Transport

Microglial Function

Inflammatory Regulation

Phagocytosis

Iron Cycling

Neuroinflammatory Response

Expression Pattern

Tissue Distribution

Brain Expression

Regulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

Iron Dysregulation

Microglial Activation

Therapeutic Implications

Parkinson's Disease

Iron Accumulation

Neuroinflammation

Genetic Associations

Amyotrophic Lateral Sclerosis (ALS)

Metal Dysregulation

Neuroinflammation

Other Neurodegenerative Conditions

Multiple Sclerosis

Huntington's Disease

Genetic Variation

Polymorphisms

Promoter Variants

Coding Variants

Disease Associations

Therapeutic Implications

Current Therapeutic Approaches

Iron Chelation

Microglial Modulation

Gene Therapy

Emerging Strategies

Challenges

Research Directions

Current Knowledge Gaps

Future Research Priorities

Interaction Network

Metal Transport Partners

Signaling Pathways

Protein Interactions

See Also

External Links

References

Pathway Diagram

💬 Discussion